Global Computational Immunology Market Growth (Status and Outlook) 2023-2029

Global Computational Immunology Market Growth (Status and Outlook) 2023-2029

Computational Immunology is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.

LPI (LP Information)' newest research report, the “Computational Immunology Industry Forecast” looks at past sales and reviews total world Computational Immunology sales in 2022, providing a comprehensive analysis by region and market sector of projected Computational Immunology sales for 2023 through 2029. With Computational Immunology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Computational Immunology industry.

This Insight Report provides a comprehensive analysis of the global Computational Immunology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Computational Immunology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Computational Immunology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Computational Immunology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Computational Immunology.

The global Computational Immunology market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Computational Immunology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Computational Immunology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Computational Immunology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Computational Immunology players cover EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group and Compugen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Computational Immunology market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling

Segmentation by application
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology of Immune Epitopes
Immune Epitope Database

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co

Please note: The report will take approximately 2 business days to prepare and deliver.